Drug-eluting stent with Endoboost Technology™.
This is the parallax effect with the video or gallery background images
ihtDEStiny®, our DES with Endoboost Technology™: A unique combination of design features engineered to deliver low thrombogenicity, early vascular healing, and optimal stent integration.
Outstanding navigability with low entry and crossing profiles for effortless lesion access.
Ultrathin-strut DES (≤70 µm) were associated with a 15 % lower long-term target lesion failure compared with conventional thin-strut DES in a meta-analysis of >20,000 patients from 16 randomized trials.
Thinner struts are associated with better clinical results.
Stent material | Chromium-cobalt |
Average strut thickness | 68 μm (0.068 mm) |
Drug | Sirolimus |
Polymer | Biostable acrylic polymer |
Compatibility of the guide wire (max) | 0.014” (0.36 mm) |
Guiding catheter compatibility | 5F |
Positioning marks | Brachial and femoral in the hypotube area |
Delivery system workable length | 141 cm |
Foreshortening | ≤2.0% nominal |
Access expert clinicians and medical advice.
Advanced, clinically-proven medications.
4.5* from over 25,000 people like you.
Regulated by the Care Quality Commission.
Reliable closed vacuum drainage system for efficient post-surgical fluid evacuation. Safe and effective wound drainage to help reduce infection risks and faster wound healing.
Polyurethane self-adhesive dressing with pad
Polyester non-woven fabric self-adhesive dressing with pad
ADHESIVE STRIP FOR CUTANEOUS SUTURES
Explore our three therapeutic areas to discover how our solutions enhance procedural control, ensure treatment safety, and improve long-term patient outcomes. Our approach is built on a deep understanding of complex clinical needs and a commitment to practical, effective solutions.
By providing advanced securement and protection solutions, this unit is dedicated to maintaining the integrity of the vascular access system and ensuring patient safety throughout the duration of treatment. Our medical products minimize risk and improve clinician confidence.
Our cardiology portfolio is engineered to optimize procedural outcomes in high-complexity coronary interventions. We provide specialists with the tools needed to navigate the most challenging clinical scenarios.
We focus on the high-stakes environment of the interventional neuroradiology field offering total procedural control and visual clarity during the endovascular treatment of complex vascular pathologies. Our specialized medical devices ensure that critical medical care is delivered with absolute precision.
Our clinical and commercial teams provide close, personalized support. Contact us for technical specifications, product usage guidelines, or public tender collaboration inquiries.
The ihtDestiny® sirolimus-eluting stent is indicated for coronary artery disease. Healthcare professionals must review instructions for technical specifications, potential complications, and contraindications before deployment.
